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httpExperience with a new negative pressure incision
management system in prevention of groin wound
infection in vascular surgery patients
Tim Matatov, MD,a Kaavya N. Reddy, MD,a Linda D. Doucet, RN,a Cynthia X. Zhao, MD, MPH,b and
Wayne W. Zhang, MD,a Shreveport, La
Objective: Groin wound infection is an important cause of postoperative morbidity in vascular surgery patients, especially
when prosthetic grafts are involved. The objective of this study was to investigate if Prevena (Kinetic Concepts, Inc, San
Antonio, Tex), a negative pressure incision management system, could reduce the risk of groin wound infection in
patients after vascular surgery.
Methods: Ninety patients (115 groin incisions) underwent longitudinal or transverse femoral cutdown for vascular
procedures. A retrospective chart review was performed on 63 consecutive incisions in patients in the non-Prevena group
from December 2009 to November 2010 and on 52 consecutive incisions in patients in the Prevena group from January
2011 to December 2011. Prevena was applied intraoperatively and removed 5 to 7 days postoperatively. The non-Prevena
group received either a skin adhesive or absorbent dressing. Groin incisions were assessed, and infection was graded
based on Szilagyi classiﬁcations. Student t-test and two-sample proportion z test were used for statistical analyses.
A P value < .05 was considered statistically signiﬁcant.
Results: Comorbidities and known risk factors for infection were compared; there were no statistically signiﬁcant
differences between the two groups. Prosthetic material was used in 34 (65%) incisions in the Prevena group and 29 (46%)
incisions in the non-Prevena group. Fifty (96%) incisions within the Prevena group and 60 (96%) in the non-Prevena
group were classiﬁed as clean surgical wounds. Wounds were evaluated at 7 days and 30 days postoperatively. Of
63 groin incisions in 49 patients in the non-Prevena group, 19 (30%) incisions had groin wound infections. Wound
infections were classiﬁed into Szilagyi grade I (10; 16%), Szilagyi grade II (7; 11%), and Szilagyi grade III (2; 3%). Of
52 groin incisions in 41 patients in the Prevena group, three (6%) incisions had Szilagyi grade I wound infections. No
grade II or III infections occurred in this group. Overall incidence of infection between the two groups was statistically
signiﬁcant (P [ .0011).
Conclusions: In this clinical study, Prevena negative pressure dressing signiﬁcantly decreased the incidence of groin wound
infection in patients after vascular surgery. (J Vasc Surg 2013;57:791-5.)The incidence of surgical site infections (SSIs) at the
groin after vascular procedures is 3% to 44%.1-8 This re-
ported incidence is up to ﬁve times higher than the
expected incidence of infection in clean cases as predicted
by the U.S. Centers for Disease Control and Prevention
National Nosocomial Infections Surveillance System.9
Factors contributing to increased incidence of SSIs in this
subset of patients include disruption of lymphatics, prox-
imity of the groin to the perineum, and prosthetic graft
placement.1,10 Morbidity associated with infection includes
limb loss, sepsis, prolonged hospital stay, and increasedthe Division of Vascular and Endovascular Surgery, Department of
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these infections. Multiple treatment modalities have been
attempted with limited success and increased health care
costs, including rotational ﬂaps, wound vacuum-assisted
closure, and excision of prostheses with extra-anatomic
bypass. Standard infection prevention measures such as
preoperative antibiotics have signiﬁcantly decreased SSIs.
However, even when combined with other preventive
techniques, such as oblique incisions, use of antibiotic-
impregnated grafts, meticulous wound closure, and closed
suction drain placement, wound infection rates in this
subset of patients remain substantially higher than the
accepted norm for clean cases.7,11 Because most bacterial
infections occur from direct spread of bacteria from the
wound, prevention must be given just as much importance
as treatment.11 The aim of this study was to investigate if
a new negative pressure incision management system,
Prevena (Kinetic Concepts, Inc, San Antonio, Tex), could
reduce the incidence of groin wound infections after
vascular surgery.
METHODS
This study was approved by institutional review
committee at Louisiana State University Health Sciences791
Fig. Intraoperative application of Prevena negative pressure
dressing after femoral-femoral bypass.
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retrospectively studied the charts of 90 consecutive patients
(115 groin incisions) who underwent femoral cutdown for
vascular procedures. The patient population was divided
into a “Prevena group” and a “non-Prevena group.”
From December 2009 to November 2010, 63 consecutive
incisions in the non-Prevena group were reviewed, and 52
consecutive incisions were reviewed in the Prevena group
from January 2011 to December 2011. In the non-
Prevena group, skin was covered using Primapore (Smith
& Nephew UK, London, UK), which was removed 3
days postoperatively, or Dermabond Adhesive (Ethicon
Inc, Somerville, NJ). In the Prevena group, Prevena was
applied intraoperatively under sterile conditions (Fig) and
removed 5 to 7 days postoperatively. Patients underwent
preoperative hair clipping and were prepared with iodo-
phor (DuraPrep; 3M, St. Paul, Minn) or povidone-iodine
(Betadine; Purdue Products L.P., Stamford, Conn) for
pre-existing open wounds or chlorhexidine in iodine-
allergic patients. Patients received cefazolin, or clindamycin
if allergic to penicillin, 30 minutes before incisions. In the
patients who had been receiving antibiotics for lower
extremity open wound infection or sepsis at the time of
the vascular procedure, therapeutic antibiotic doses were
given again within 1 hour of skin incision. The orientation
of the incision was based on the site of vascular access. All
incisions were reapproximated in three layers of running
polyglactin 910 suture (Vicryl; Ethicon Inc, Somerville,
NJ) for subcutaneous tissue, and skin was closed in a subcu-
ticular fashion with poliglecaprone 25 (Monocryl; Ethicon
Inc). After closure, incisions and surrounding skin were
clean and dried with sterile gauzes. The Prevena dressing
was placed by covering the incision with the foam bolster
in the center and then surrounding adhesive dressing to
intact skin. Negative pressure was applied, and a complete
seal was conﬁrmed.
Attending physicians evaluated wound appearance on
postoperative day 5 to 7 and at 1-month follow-up or
sooner if patients presented with symptoms or signs of
wound infection (mean follow-up was 7 days and 33 days
in the Prevena group and 10 days and 40 days in the
non-Prevena group). Groin wound infection in both
groups was graded according to the Szilagyi grading
system. Incidences of infection with different grades were
recorded and analyzed.
All patients who underwent longitudinal or transverse
incisions for groin cutdown were eligible for inclusion in
this study. Patients who could not have Prevena placed
because of the inability to obtain a seal were excluded.
Two morbidly obese patients were excluded because
a complete seal with Prevena dressing could not be
achieved owing to the patients’ giant pannus.
Szilagyi classiﬁcation was used to describe SSIs.12 Grade
I infections had only dermal involvement. Grade II infec-
tions extended to the subcutaneous region but did not
involve the arterial graft. Infection that involved the arterial
graft was grade III. If a patient presented initially with
a lower grade of infection but then developed a higher gradebecause of failure of medical or surgical treatment, the
patient was placed into the higher category. Localized infec-
tion was deﬁned as acute or chronic ipsilateral lower
extremity infection occurring before vascular surgery. Renal
insufﬁciency was deﬁned as glomerular ﬁltration rate <50,
and anemia was deﬁned as hemoglobin <12 g/dL.
Student t-test and two-sample proportion z test were
used for statistical analyses. A P value < .05 was considered
statistically signiﬁcant.
RESULTS
Comorbidities such as diabetes and coronary artery
disease and other known risk factors for infection such as
cigarette smoking and body mass index were compared
between the two groups, and there was no statistically
signiﬁcant difference (Table I). No patients required hemo-
dialysis or peritoneal dialysis. Prosthetic material was used
in 34 incisions (65%) in the Prevena group and 29 incisions
(46%) in the non-Prevena group. Prosthetic material was
subdivided further into polytetraﬂuoroethylene or polyeth-
ylene terephthalate (Dacron) (Table II). In the Prevena
group, 40 incisions (77%) were longitudinal, and 12 inci-
sions (23%) were transverse. In the non-Prevena group,
47 incisions (75%) were longitudinal, and 16 incisions
(25%) were transverse. There was no statistically signiﬁcant
difference in the incision types of longitudinal vs transverse
between the two groups. Of the 22 infected incisions in
both groups, 16 incisions were longitudinal and six were
transverse.
Groin exposure was performed for revascularization,
endovascular, or other vascular procedures (Table II).
The number of patients with a history of revascularization
or amputation was greater in the Prevena group (17; 41%)
compared with the non-Provena group (12; 24%), but this
was not statistically signiﬁcant (P ¼ .0844). The presence
of a localized or systemic infection at the time of operation
was not statistically signiﬁcant between the two groups.
Perioperative risk factors were compared as well
Table I. Patient characteristics
Prevena
group
Non-Prevena
group P
Number of patients 41 49
Number of groin incisions 52 63
Gender
Male 27 (66%) 33 (67%)
Female 14 (34%) 16 (33%)
Mean age, years 52 (range,
23-79)
56 (range,
21-85)
.1445
Current smoker 27 (66%) 29 (59%) .4952
Mean BMI 26 (range,
17-36)
27 (range,
19-42)
.3447
DM 14 (34%) 13 (27%) .4713
COPD 16 (39%) 24 (49%) .3417
CAD 25 (61%) 27 (55%) .5661
CHF 7 (17%) 9 (18%) .9011
Hypertension 31 (76%) 42 (86%) .2242
Localized infection 14 (34%) 13 (27%) .4713
Sepsis 3 (7%) 5 (10%) .6138
Renal insufﬁciency 8 (20%) 3 (6%) .0446
Anemia 24 (59%) 21 (43%) .1306
Previous revascularization/
amputation
17 (41%) 12 (24%) .0844
Previous femoral cutdown 7 (17%) 8 (16%) .8986
Bleeding disorder 1 (2%) 0
Steroid use 0 1 (2%)
Mean preoperative albumin 3.1 3.1
Mean ASAa 3 3
ASA, American Society of Anesthesiologists; BMI, body mass index; CAD,
coronary artery disease; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary disease; DM, diabetes mellitus.
aASA classiﬁcation (1963) is a ﬁve-category physical status classiﬁcation
system for assessing a patient before surgery.
Table II. Perioperative characteristics
Prevena
group
Non-Prevena
group P
Wound classiﬁcationa
Clean 50 (96%) 60 (95%)
Clean-contaminated 1 (2%) 0
Contaminated 0 1 (2%)
Dirty 1 (2%) 2 (3%)
Prosthetic material used
PTFE 27 (52%) 26 (41%) .2388
Dacronb 7 (13%) 3 (5%) .1281
Incision type
Longitudinal 40 (77%) 47 (75%) .8029
Transverse 12 (23%) 16 (25%) .8029
Procedure type
Revascularization 29 (71%) 31 (63%) .4839
EVAR/TEVAR 10 (24%) 11 (24%) .8103
Pseudoaneurysm 2 (5%) 7 (14%) .1499
Emergency 9 (22%) 8 (13%) .2587
Perioperative blood
transfusion
11 (27%) 16 (33%) .5372
Mean operative time,
minutes
184 (range,
77-307)
175 (range,
67-298)
.4915
EVAR/TEVAR, Endovascular aortic repair/thoracic endovascular aortic
repair; PTFE, polytetraﬂuoroethylene.
aCenters of Disease Control and Prevention Hospital Infection Control
Practices Advisory Committee (HICPAC).
bPolyethylene terephthalate.
Table III. Incidence and Szilagyi grades of infection
based on total number of incisions
Prevena group Non-Prevena group P
Szilagyi grade I 3 (6%) 10 (16%)
Szilagyi grade II 0 7 (11%)
Szilagyi grade III 0 2 (3%)
Overall infection 3 (6%) 19 (30%) .0011
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and second wound evaluation was 7 days and 33 days post-
operatively vs 10 days and 40 days postoperatively in the
non-Prevena group. In the non-Prevena group, seven inci-
sions healed without evidence of infection at 1-week
follow-up. These patients reported no problem with heal-
ing and did not return to the clinic for the second wound
evaluation at 1 month. In the non-Prevena group, wound
infection was diagnosed 3 to 20 days (mean, 11.8 days)
postoperatively. In the Prevena group, timing of infection
was 5 to 12 days (mean, 9 days) postoperatively.
Total infection rates were 30% (19/63) in the non-
Prevena group and 6% (3/52) in the Prevena group
(Table III). Of the 19 (30%) patients with infected
incisions in the non-Prevena group, 10 (16%) developed
Szilagyi grade I infection, seven (11%) developed
grade II infection, and two (3%) developed grade III
infection. Patients with grade III infection subsequently
underwent excision of the infected graft with extra-
anatomic bypass. One of those patients eventually
required an amputation.
In the non-Prevena group, eight incisions were redo
incisions with previous ipsilateral femoral cutdown. Two
patients developed grade I infection, one developed grade
II infection, and one developed grade III infection. Among
seven redo incisions in the Prevena group, one patientdeveloped grade I infection; there were no grade II or
III infections.
In the Prevena group, 3 to 10 mL of ﬂuid was recov-
ered in the tubing and canisters from 37 (71%) of the inci-
sions. In the remaining 15 (29%) incisions, no ﬂuid was
drained out, and three of these patients developed Szilagyi
grade I infection. All three patients were successfully
treated with a 7-day course of oral antibiotics. No grade
II or III infections occurred in this group. The Prevena
group had a statistically signiﬁcantly lower incidence of
groin wound infection (P ¼ .0011). The incidence of grade
I and III infections was lower in the Prevena group,
although this was not statistically signiﬁcant (Table III);
this may be due to type II statistical error from relatively
small samples. No deaths occurred in either group.
DISCUSSION
An SSI at the groin in a patient after a vascular proce-
dure can have a disastrous outcome leading to limb loss
and death. Groin incisions are prone to complications
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and hematomas.7 Prevention of SSIs is just as important
as and much more cost-effective than treatment. On
average, SSIs increase hospital stay by 9.7 days and increase
cost by approximately $20,842 per admission.13 A single
Prevena unit cost is $495; although this is signiﬁcantly
greater than other dressings, the use of Provena may poten-
tially save on in-hospital stay cost and treatment of infec-
tion. In this study, total cost of 52 Prevena units was
$25,740. However, no patient needed an extended
hospital stay, and only three patients received oral antibi-
otics for 1 week. In the non-Prevena group, two patients
with Szilagyi grade III wound infections required long
hospitalization with a cost >$45,000. This ﬁgure does
not include the cost of seven grade II and 10 grade I SSIs.
Many authors have studied vascular groin site infection
and how to prevent them. Stewart et al11 performed
a meta-analysis of 34 randomized controlled trials to
determine the effectiveness of perioperative strategies in
preventing infection in patients undergoing peripheral arte-
rial reconstruction. These investigators concluded that
although there was clear evidence supporting prophylactic
antibiotics for vascular reconstruction, their data did not
support the effectiveness of other preventive techniques,
such as rifampin-bonded grafts, preoperative skin anti-
sepsis, suction wound drainage, minimally invasive in situ
bypass techniques, intraoperative glove change, and
different wound closure techniques. Our study patients
routinely received perioperative antibiotics. Aside from an
increased incidence of renal insufﬁciency in the Prevena
group, there were no signiﬁcant differences between the
two patient groups, and we found that placement of
a negative pressure wound management system resulted
in a statistically signiﬁcantly lower incidence of infection
overall.
Easterlin et al14 reported that a drawback of sutures
and staples is that they are tensioning devices, which
concentrate the spreading force to small points along the
incision. These tension points may result in ischemia and
possibly necrosis of the tissue. The rationale of a negative
pressure dressing includes holding incision edges together,
protecting the incision from external infectious sources,
and removing ﬂuid and infectious materials from the
surgical site. Prevena application adds approximately
10 minutes of intraoperative time, which was not statisti-
cally signiﬁcant in this study. Although there are other
negative pressure wound management systems currently
in use,15 Prevena differs from these because the interface
layer is a polyester knit fabric that performs the same func-
tions as a nonadhering dressing in that it protects the skin
from contact with the foam bolster, while allowing delivery
of negative pressure and ﬂuid removal.16,17 Current nega-
tive pressure wound management systems do not have
this barrier between the wound and the foam bolster.
We believe that the lower incidence of wound infection
with Prevena is multifactorial. Not only does Prevena
decrease lateral tension on the wound and act as a dressing
to provide a sterile environment for wound healing, butalso the negative pressure may decrease lymphocele
formation (as lymphatics are often transected during this
type of incision), which prevents skin edges from becoming
macerated, promoting epithelialization. Patients were
noted to have 0 to 10 mL of ﬂuid in the Prevena tubing
and canister at the time of removal. In our three patients
in the Prevena group who presented with Szilagyi I infec-
tions, all had 0 mL output in the Prevena canister. Prevena
dressings in these patients were functioning properly.
Absence of ﬂuid in the tubing or canister may be due to
tight wound closure. In addition, the presence of ﬂuid in
the foam bolster was difﬁcult to quantify, but we knew
that it was present because ﬂuid droplets accumulated
throughout the polyurethane shell encapsulating the
foam bolster. Simple placement of an occlusive dressing
may contribute to decreased groin wound infection.
However, most of the incisions (71%) in the Prevena group
had 3 to 10 mL of collectable ﬂuid sucked out. Removing
even a small amount of proinﬂammatory ﬂuid and
decreasing wound edema may prove to be beneﬁcial. Based
on our limited data, it cannot be suggested that absence of
ﬂuid in the tubing or canisters of Prevena is associated with
incision infection. Further investigation is needed to draw
this conclusion. A randomized prospective clinical trial
comparing simple occlusive dressing with the Prevena
negative pressure wound management system would be
valuable.
CONCLUSIONS
Overall, Prevena negative pressure dressing combined
with standard perioperative infection prevention signiﬁ-
cantly decreases the incidence of groin SSIs in patients
undergoing vascular procedures.
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